Donor-derived CAR-T Cells in the Treatment of AML Patients
Clinical trial NCT04766840 · UNKNOWN
Trial details
- NCT number
- NCT04766840
- Sponsor
- Beijing Immunochina Medical Science & Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2023-06-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.